R-CDOP regimen: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{SI}} {{CMG}}; {{AE}} {{AV}} ==Overview== {{PAGENAME}} refers to a regimen consisting of rituximab, cyclophosphamide, liposomal doxorubicin|doxorubic...")
 
No edit summary
 
Line 3: Line 3:


==Overview==  
==Overview==  
{{PAGENAME}} refers to a regimen consisting of [[rituximab]], [[cyclophosphamide]], liposomal [[doxorubicin|doxorubicin (Caelyx)]], [[vincristine]], [[prednisone]] used to treat [[non-Hodgkin lymphoma]].<ref name="pmid12161358">{{cite journal| author=Martino R, Perea G, Caballero MD, Mateos MV, Ribera JM, de Oteyza JP et al.| title=Cyclophosphamide, pegylated liposomal doxorubicin (Caelyx), vincristine and prednisone (CCOP) in elderly patients with diffuse large B-cell lymphoma: results from a prospective phase II study. | journal=Haematologica | year= 2002 | volume= 87 | issue= 8 | pages= 822-7 | pmid=12161358 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12161358 }} </ref>
{{PAGENAME}} refers to a regimen consisting of [[rituximab]], [[cyclophosphamide]], liposomal [[doxorubicin|doxorubicin (Caelyx)]], [[vincristine]], [[prednisone]] used to treat [[non-Hodgkin lymphoma]].<ref name="pmid12161358">{{cite journal| author=Martino R, Perea G, Caballero MD, Mateos MV, Ribera JM, de Oteyza JP et al.| title=Cyclophosphamide, pegylated liposomal doxorubicin (Caelyx), vincristine and prednisone (CCOP) in elderly patients with diffuse large B-cell lymphoma: results from a prospective phase II study. | journal=Haematologica | year= 2002 | volume= 87 | issue= 8 | pages= 822-7 | pmid=12161358 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12161358 }} </ref>


==Regimen==
==Regimen==
{{chemo|R|Rituximab}}
{{chemo|R|Rituximab}}
{{chemo|C|Cyclophosphamide}}
{{chemo|C|Cyclophosphamide}}
{{chemo|D|Doxorubicin (Caelyx)}}
{{chemo|D|Doxorubicin (Caelyx)}}
{{chemo|O|Vincristine (Oncovin)}}
{{chemo|O|Vincristine (Oncovin)}}


Line 15: Line 17:


==Indications==
==Indications==
*[[Non-Hodgkin lymphoma]].<ref name="pmid12161358">{{cite journal| author=Martino R, Perea G, Caballero MD, Mateos MV, Ribera JM, de Oteyza JP et al.| title=Cyclophosphamide, pegylated liposomal doxorubicin (Caelyx), vincristine and prednisone (CCOP) in elderly patients with diffuse large B-cell lymphoma: results from a prospective phase II study. | journal=Haematologica | year= 2002 | volume= 87 | issue= 8 | pages= 822-7 | pmid=12161358 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12161358 }} </ref>
*[[Non-Hodgkin lymphoma]].<ref name="pmid12161358">{{cite journal| author=Martino R, Perea G, Caballero MD, Mateos MV, Ribera JM, de Oteyza JP et al.| title=Cyclophosphamide, pegylated liposomal doxorubicin (Caelyx), vincristine and prednisone (CCOP) in elderly patients with diffuse large B-cell lymphoma: results from a prospective phase II study. | journal=Haematologica | year= 2002 | volume= 87 | issue= 8 | pages= 822-7 | pmid=12161358 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12161358 }} </ref>


==References==
==References==
{{Reflist|2}} 


{{Reflist|2}}  [[Category:Chemotherapy regimens]]
[[Category:Chemotherapy regimens]]

Latest revision as of 20:12, 27 March 2015

WikiDoc Resources for R-CDOP regimen

Articles

Most recent articles on R-CDOP regimen

Most cited articles on R-CDOP regimen

Review articles on R-CDOP regimen

Articles on R-CDOP regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on R-CDOP regimen

Images of R-CDOP regimen

Photos of R-CDOP regimen

Podcasts & MP3s on R-CDOP regimen

Videos on R-CDOP regimen

Evidence Based Medicine

Cochrane Collaboration on R-CDOP regimen

Bandolier on R-CDOP regimen

TRIP on R-CDOP regimen

Clinical Trials

Ongoing Trials on R-CDOP regimen at Clinical Trials.gov

Trial results on R-CDOP regimen

Clinical Trials on R-CDOP regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on R-CDOP regimen

NICE Guidance on R-CDOP regimen

NHS PRODIGY Guidance

FDA on R-CDOP regimen

CDC on R-CDOP regimen

Books

Books on R-CDOP regimen

News

R-CDOP regimen in the news

Be alerted to news on R-CDOP regimen

News trends on R-CDOP regimen

Commentary

Blogs on R-CDOP regimen

Definitions

Definitions of R-CDOP regimen

Patient Resources / Community

Patient resources on R-CDOP regimen

Discussion groups on R-CDOP regimen

Patient Handouts on R-CDOP regimen

Directions to Hospitals Treating R-CDOP regimen

Risk calculators and risk factors for R-CDOP regimen

Healthcare Provider Resources

Symptoms of R-CDOP regimen

Causes & Risk Factors for R-CDOP regimen

Diagnostic studies for R-CDOP regimen

Treatment of R-CDOP regimen

Continuing Medical Education (CME)

CME Programs on R-CDOP regimen

International

R-CDOP regimen en Espanol

R-CDOP regimen en Francais

Business

R-CDOP regimen in the Marketplace

Patents on R-CDOP regimen

Experimental / Informatics

List of terms related to R-CDOP regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Overview

R-CDOP regimen refers to a regimen consisting of rituximab, cyclophosphamide, liposomal doxorubicin (Caelyx), vincristine, prednisone used to treat non-Hodgkin lymphoma.[1]

Regimen

RRituximab

CCyclophosphamide

DDoxorubicin (Caelyx)

OVincristine (Oncovin)

PPrednisone

Indications

References

  1. 1.0 1.1 Martino R, Perea G, Caballero MD, Mateos MV, Ribera JM, de Oteyza JP; et al. (2002). "Cyclophosphamide, pegylated liposomal doxorubicin (Caelyx), vincristine and prednisone (CCOP) in elderly patients with diffuse large B-cell lymphoma: results from a prospective phase II study". Haematologica. 87 (8): 822–7. PMID 12161358.